CCL22

CCL22 Molekülinformation

Englischer Name	ATP Binding Cassette Subfamily D Member 1	Anzahl der inverkehr gebrachten Arzneimittel	1
Anzahl der klinischen Arzneimittel	2	Target-Alias	ATP Binding Cassette Subfamily D Member 1，Adrenoleukodystrophy Protein，ATP-Binding Cassette Sub-Family D Member 1，ALDP，ATP-Binding Cassette， Sub-Family D (ALD)， Member 1，ABC42，ABCD1，AMN，ALD，ATP Binding Cassette Transporter， Subfamily D， Member 1，Adrenoleukodystrophy
Höchste Forschungs- und Entwicklungsphase	Approved

Englischer Name	ATP Binding Cassette Subfamily D Member 1
Target-Alias	ATP Binding Cassette Subfamily D Member 1，Adrenoleukodystrophy Protein，ATP-Binding Cassette Sub-Family D Member 1，ALDP，ATP-Binding Cassette， Sub-Family D (ALD)， Member 1，ABC42，ABCD1，AMN，ALD，ATP Binding Cassette Transporter， Subfamily D， Member 1，Adrenoleukodystrophy
Anzahl der inverkehr gebrachten Arzneimittel	1
Anzahl der klinischen Arzneimittel	2
Höchste Forschungs- und Entwicklungsphase	Approved

CCL22 Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
Fc Tag (1)
Marker
Unconjugated (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
CC2-H5257	Human	HEK293	Human CCL22 / MDC Protein, Fc Tag				In den Warenkorb legen

Gesamtmenge1

CCL22 Molekülhintergrund

This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for monocytes, dendritic cells, natural killer cells and for chronically activated T lymphocytes. It also displays a mild activity for primary activated T lymphocytes and has no chemoattractant activity for neutrophils, eosinophils and resting T lymphocytes. The product of this gene binds to chemokine receptor CCR4. This chemokine may play a role in the trafficking of activated T lymphocytes to inflammatory sites and other aspects of activated T lymphocyte physiology.

CCL22 Molekülalias

MDC,ABCD-1,SCYA22,STCP-1,DC,B-CK,A-152E5.1

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Pozetaldogene ormesparvovec	SBT-101	Phase 2 Clinical	SwanBio Therapeutics Ltd	Adrenoleukodystrophy	Details
TYF-ABCD1	TYF-ABCD1	Clinical	Shenzhen Geno-Immune Medical Institute	Adrenoleukodystrophy	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Elivaldogene autotemcel		Approved	Genetix Biotherapeutics Inc, Inserm	Lenti-D, Skysona	United States	Adrenoleukodystrophy	Genetix Biotherapeutics Inc	2021-07-27	Adrenoleukodystrophy	Details